Hint mode is switched on Switch off
For swift navigation between sections

LianBio

PDF download

Choose all Reset all
Download Cancel
Organization name
LianBio
Country name
Cayman Islands
Country of registration
Cayman Islands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets.

Awards

News

09/02/2024 LianBio: Costs Associated With Exit Or Disposal Activities, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
22/12/2023 LianBio: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement
16/12/2023 LianBio: Departure Of Directors Or Certain Officers; Election Of Directors; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
06/12/2023 LianBio: Regulation Fd Disclosure, Financial Statements And Exhibits
30/11/2023 LianBio: Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001831283
Registration is required to get access.